d-glucaro-delta-lactam has been researched along with Experimental Hepatoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azetaka, M; Fukuyasu, H; Hosokawa, M; Iizuka, Y; Inouye, S; Kobayashi, H; Tsuruoka, T | 1 |
| Hamada, J; Hosokawa, M; Kobayashi, H; Kuramitsu, Y; Morikawa, K; Tsuruoka, T | 1 |
2 other study(ies) available for d-glucaro-delta-lactam and Experimental Hepatoma
| Article | Year |
|---|---|
Inhibition of pulmonary metastases and tumor cell invasion in experimental tumors by sodium D-glucaro-delta-lactam (ND2001).
Topics: Animals; Antineoplastic Agents; Female; Fibrosarcoma; Glucaric Acid; Liver Neoplasms, Experimental; Lung Neoplasms; Male; Mammary Neoplasms, Experimental; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Invasiveness; Rats; Rats, Inbred SHR; Tumor Cells, Cultured | 1995 |
A new anti-metastatic drug, ND-2001, inhibits lung metastases in rat hepatoma cells by suppressing haptotaxis of tumor cells toward laminin.
Topics: Animals; Antineoplastic Agents; Chemotaxis; Female; Glucaric Acid; Laminin; Liver Neoplasms, Experimental; Lung Neoplasms; Neoplasm Metastasis; Rats; Rats, Wistar; Tumor Cells, Cultured | 1998 |